Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00689026 · ClinicalTrials.gov registry record · NA
Efficacy of Lubiprostone in Combination With Standard PEG Preparation
A NA study, sponsored by Augusta University.
- Terminated
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00689026 is a NA study that was terminated before completion, run by Augusta University. The registered enrollment target is 60 participants.
The verdict
NCT00689026, a NA study, was terminated before completion, sponsored by Augusta University.
- TERMINATED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
A large population-based study has shown diabetes to be an independent risk factor for colon cancer compared to the general population. Thus, the completion of an adequately prepped colonoscopy is requisite in providing diabetics with adequate colon cancer screening. Recent data has shown that diabetic patients have poorer response to bowel cleansing compared to non-diabetics (with a standard PEG prep, only 62% of diabetic patients had their colonoscopy preps rated as good or better vs. 97% of normal patients, p\<0.001). This may be due to the fact that a majority of diabetic patients report constipation as a common gastrointestinal complaint. We postulate that lubiprostone (Amitiza), in combination with PEG, will have additional efficacy over standard PEG preparation, and provide optimal safe and effective colonic cleansing for diabetics.
Interventions
- DRUG Lubiprostone
- OTHER Polyethylene glycol with electrolytes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00689026
The ClinicalTrials.gov registry entry for NCT00689026 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lubiprostone is the first listed.
NCT00689026 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00689026 about?
NCT00689026 is a clinical study titled "Efficacy of Lubiprostone in Combination With Standard PEG Preparation". A large population-based study has shown diabetes to be an independent risk factor for colon cancer compared to the general population. Thus, the completion of an adequately prepped colonoscopy is requisite in providing diabetics with adequate colon cancer screening. Recent data has shown that diab...
What is the current status of trial NCT00689026?
This trial is currently terminated. It is a NA study. The enrollment target is 60 participants. The study started on 2008-05. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00689026?
The interventions under investigation include: Lubiprostone (DRUG), Polyethylene glycol with electrolytes (OTHER).
Who is sponsoring clinical trial NCT00689026?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.